0 likes | 1 Vues
Explore Healtharku2019s insights on the most impactful mergers and acquisitions reshaping healthcare & life sciences, highlighting innovation and strategic drivers.
E N D
Top Mergers & Acquisitions Shaping the Healthcare & Life Sciences Industry
Top Mergers & Acquisitions Shaping the Healthcare and Life Sciences Industry ACQUIREE ACQUIRER Stryker’s acquisition of Inari Medical for $4.90Bn strengthens its neurovascular business, expanding into the peripheral vascular market with innovative thrombectomy devices for clot-related diseases. Value: $4.90 Bn February 19, 2025 Date: ACQUIREE ACQUIRER Lundbeck's acquisition of bexicaserin for $2.60 Bn from Longboard to boost its neuro-rare disease portfolio, targeting severe epileptic disorders like DEEs, with FDA Breakthrough Therapy designation. Value: $2.60 Bn December 2, 2024 Date:
Top Mergers & Acquisitions Shaping the Healthcare and Life Sciences Industry ACQUIREE ACQUIRER Novartis' acquisition of Mariana Oncology for $1.75 Bn to boost its radioligand therapy pipeline, including MC-339 for small-cell lung cancer, diversify actinium assets, and strengthen clinical supply capabilities. Value: $1.75 Bn May 2, 2024 Date: ACQUIREE ACQUIRER Johnson & Johnson's acquisition of V-Wave for $1.70 Bn to strengthen its cardiovascular portfolio with the Ventura® Interatrial Shunt, targeting heart failure with FDA Breakthrough Device designation. Value: $1.70 Bn October 9, 2024 Date:
Top Mergers & Acquisitions Shaping the Healthcare and Life Sciences Industry ACQUIREE ACQUIRER Roche's acquisition of Poseida Therapeutics for $1.50 Bn to strengthen its off-the-shelf CAR-T cell therapy pipeline with innova- tive gene-editing technology and early-stage cancer assets. Value: $1.50 Bn November 26, 2024 Date: ACQUIREE ACQUIRER AbbVie's acquisition of Aliada Therapeutics for $1.40 Bn to enhance its Alzheimer’s pipeline and CNS R&D with innovative blood-brain barrier-crossing MODEL™ technology and biologics delivery. Value: $1.40 Bn December 11, 2024 Date:
Top Mergers & Acquisitions Shaping the Healthcare and Life Sciences Industry ACQUIREE ACQUIRER MSD's acquisition of Modifi Biosciences for $1.33 Bn to strengthen its oncology pipeline with innovative DNA-based therapies for hard-to-treat cancers like glioblastomas. Value: $1.33 Bn October 23, 2024 Date: ACQUIREE ACQUIRER Edwards Lifesciences acquisition of JenaValve and Endotronix for $1.20 Bn, expanding into aortic regurgitation and heart failure management with promising new technologies and FDA approval expected by 2025. Value: $1.20 Bn July 24, 2024 Date:
Top Mergers & Acquisitions Shaping the Healthcare and Life Sciences Industry ACQUIREE ACQUIRER Hologic's acquisition of Gynesonics for $0.35 Bn to add the Sonata® System, a minimally invasive, incisionless treatment for uterine fibroids using real-time ultrasound and radiofrequency ablation. Value: $0.35 Bn January 6, 2025 Date: ACQUIREE ACQUIRER Mankind Pharma's acquisition of 100% of Bharat Serums and Vaccines for $0.17 Bn to expand its leadership in women’s health, fertility, and critical care with complex biologics and delivery platforms. Value: $0.17 Bn October 23, 2024 Date: